Document is current
Any future updates will be listed below
-
Authors
Leivas, Alejandra http://orcid.org/0000-0002-3950-9002
Valeri, Antonio
Córdoba, Laura
García-Ortiz, Almudena
Ortiz, Alejandra http://orcid.org/0000-0003-4059-8839
Sánchez-Vega, Laura
Graña-Castro, Osvaldo
Fernández, Lucía
Carreño-Tarragona, Gonzalo
Pérez, Manuel http://orcid.org/0000-0001-8839-6895
Megías, Diego
Paciello, María Liz
Sánchez-Pina, Jose http://orcid.org/0000-0002-9181-0900
Pérez-Martínez, Antonio
Lee, Dean A.
Powell, Daniel J. Jr. http://orcid.org/0000-0002-5966-8908
Río, Paula
Martínez-López, Joaquín http://orcid.org/0000-0001-7908-0063
- License Information
-
More Information
Article History
Received: 5 August 2020
Revised: 20 July 2021
Accepted: 5 August 2021
First Online: 14 August 2021
Competing interests
: DJPJ holds patents in the area of CAR-T-cell therapy. DAL declares an equity interest, advisory role, and intellectual property licensing to CytoSen Therapeutics and Kiadis Pharma, and advisory role with Caribou BioSciences and Courier Biosciences. PR has licensed medicinal products and receives research funding and equity from Rocket Pharmaceuticals, Inc., Patents & Royalties, Research Funding. The remaining authors declare no competing interests.
